CNS PHARMACEUTICALS INC
NASDAQ: CNSP (CNS Pharmaceuticals, Inc.)
Kemas kini terakhir: 12 jam lalu5.11
-0.01 (-0.20%)
| Penutupan Terdahulu | 5.12 |
| Jumlah Dagangan | 4,384 |
| Harga / Buku (P/B) | 0.410 |
| Julat 52 Minggu |
| EPS Cair (TTM) | 801.26 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.92% |
| Nisbah Semasa (MRQ) | 4.94 |
| Aliran Tunai Operasi (OCF TTM) | -17.16 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -12.32 M |
| Pulangan Atas Aset (ROA TTM) | -127.31% |
| Pulangan Atas Ekuiti (ROE TTM) | -477.53% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | CNS Pharmaceuticals, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -1.5 |
| Purata | -2.00 |
|
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.21% |
| % Dimiliki oleh Institusi | 1.17% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Barrett & Company, Inc. | 30 Jun 2026 | 8 |
| Danske Bank A/S | 30 Jun 2026 | 1 |
| Sound Income Strategies, Llc | 30 Jun 2026 | 0 |
| Mai Capital Management | 30 Jun 2026 | 0 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |